Genmab — Oktober 2017
-
@ Helge, skal du på Play senere i dag og kommentere og "igen" bekræfte, at casen er uforandret?

-
Børsen ringede
i morges. Jeg har desværre ikke tid. Står i kælderen og samler inventar til min nye butik i Rødovre Centrum. -
God arbejdslyst

-
Jeps.
-
Er den eneste dårlige nyhed den fra JP Morgan? Er der ikke noget om casen?
-
Financial Times imorges
: The 16 analysts offering 12 month price targets for Genmab A/S have a median target of 1,507.50, with a high estimate of 2,000.00 and a low estimate of 784.00. The median estimate represents a 5.27% increase from the last price of 1,432.00.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind